Skip to main content
Premium Trial:

Request an Annual Quote

Incyte and Rhône-Poulenc Become Bioinformatics Partners, Old Deal Grows

Premium

PALO ALTO, Calif.--Rhône-Poulenc Rorer has expanded its almost two-year-old agreement with Incyte to include a bioinformatics collaboration, and access to Incyte's LifeSeq Gold assembled database and LifeArray expression analysis software. Incyte could also receive future milestone payments and royalties on sales of products developed with Incyte technology and database information. Financial terms were not disclosed. Incyte will cooperate with Rhône-Poulenc scientists to provide customized bioinformatics solutions, building upon the pharmaceutical company's internal bioinformatics capabilities.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.